Display options
Cite
Mozafari O, Shorofi SA, Yousefi SS. First Report on Infant Acute Urticaria after Mother's Parenteral Use of Meglumine Antimoniate (Glucantime): A Case Report. Iran J Public Health. 2016;45(9):1217-1219
Mozafari, O., Shorofi, S. A., & Yousefi, S. S. (2016). First Report on Infant Acute Urticaria after Mother's Parenteral Use of Meglumine Antimoniate (Glucantime): A Case Report. Iranian journal of public health, 45(9), 1217-1219.
Mozafari, Omid, et al. "First Report on Infant Acute Urticaria after Mother's Parenteral Use of Meglumine Antimoniate (Glucantime): A Case Report." Iranian journal of public health vol. 45,9 (2016): 1217-1219.
Mozafari O, Shorofi SA, Yousefi SS. First Report on Infant Acute Urticaria after Mother's Parenteral Use of Meglumine Antimoniate (Glucantime): A Case Report. Iran J Public Health. 2016 Sep;45(9):1217-1219. PMID: 27957467; PMCID: PMC5149476.
Copy Download .nbib Format: NLM
Share it on

Iran J Public Health. 2016 Sep;45(9):1217-1219.

First Report on Infant Acute Urticaria after Mother's Parenteral Use of Meglumine Antimoniate (Glucantime): A Case Report.

Iranian journal of public health

Omid Mozafari, Seyed Afshin Shorofi, Seyde Sedighe Yousefi

Affiliations

  1. Dept. of Traditional Persian Medicine, School of Medicine, Student Research Committe, Mazandaran University of Medical Sciences, Sari, Iran; Dept. of Traditional Persian Medicine, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
  2. Traditional and Complementary Medicine Research Center, Mazandaran University of Medical Sciences, Sari, Iran.

PMID: 27957467 PMCID: PMC5149476

Abstract

Pentavalent antimonials are still the first drug of choice for the treatment of cutaneous leishmaniasis (CL). Like other treatments, they can cause adverse reactions including musculoskeletal pain, gastrointestinal disturbances, and mild to moderate headaches. In this paper, we report the first case of an infant who developed acute urticaria after her mother's parenteral use of meglumine antimoniate (glucantime).

Keywords: Adverse reactions; Cutaneous leishmaniasis; Meglumine antimoniate (Glucantime)

References

  1. Acta Trop. 2007 Jul;103(1):33-40 - PubMed
  2. Acta Trop. 2011 May;118(2):87-96 - PubMed
  3. Antimicrob Agents Chemother. 1998 May;42(5):1076-82 - PubMed

Publication Types